These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 16323881

  • 1. Solid-phase syntheses of olefin-containing inhibitors for HTLV-1 protease using the Horner-Emmons reaction.
    Bang JK, Naka H, Teruya K, Aimoto S, Konno H, Nosaka K, Tatsumi T, Akaji K.
    J Org Chem; 2005 Dec 09; 70(25):10596-9. PubMed ID: 16323881
    [Abstract] [Full Text] [Related]

  • 2. Solid-phase synthesis of HTLV-1 protease inhibitors containing hydroxyethylamine dipeptide isostere.
    Akaji K, Teruya K, Aimoto S.
    J Org Chem; 2003 Jun 13; 68(12):4755-63. PubMed ID: 12790579
    [Abstract] [Full Text] [Related]

  • 3. Design, synthesis and structure-activity study of shorter hexa peptide analogues as HIV-1 protease inhibitors.
    Narendra Babu SN, Rangappa KS.
    Bioorg Med Chem; 2008 Jan 15; 16(2):874-80. PubMed ID: 17981043
    [Abstract] [Full Text] [Related]

  • 4. Organocatalytic sequential alpha-amination-Horner-Wadsworth-Emmons olefination of aldehydes: enantioselective synthesis of gamma-amino-alpha,beta-unsaturated esters.
    Kotkar SP, Chavan VB, Sudalai A.
    Org Lett; 2007 Mar 15; 9(6):1001-4. PubMed ID: 17295495
    [Abstract] [Full Text] [Related]

  • 5. Solid phase synthesis of selective caspase-3 peptide inhibitors.
    Grimm EL, Roy B, Aspiotis R, Bayly CI, Nicholson DW, Rasper DM, Renaud J, Roy S, Tam J, Tawa P, Vaillancourt JP, Xanthoudakis S, Zamboni RJ.
    Bioorg Med Chem; 2004 Mar 01; 12(5):845-51. PubMed ID: 14980595
    [Abstract] [Full Text] [Related]

  • 6. High-speed synthesis of potent C2-symmetric HIV-1 protease inhibitors by in-situ aminocarbonylations.
    Wannberg J, Kaiser NF, Vrang L, Samuelsson B, Larhed M, Hallberg A.
    J Comb Chem; 2005 Mar 01; 7(4):611-7. PubMed ID: 16004505
    [Abstract] [Full Text] [Related]

  • 7. Synthesis and activity of tetrapeptidic HTLV-I protease inhibitors possessing different P3-cap moieties.
    Zhang M, Nguyen JT, Kumada HO, Kimura T, Cheng M, Hayashi Y, Kiso Y.
    Bioorg Med Chem; 2008 May 15; 16(10):5795-802. PubMed ID: 18400502
    [Abstract] [Full Text] [Related]

  • 8. Application of thiol-olefin co-oxygenation methodology to a new synthesis of the 1,2,4-trioxane pharmacophore.
    O'Neill PM, Mukhtar A, Ward SA, Bickley JF, Davies J, Bachi MD, Stocks PA.
    Org Lett; 2004 Sep 02; 6(18):3035-8. PubMed ID: 15330581
    [Abstract] [Full Text] [Related]

  • 9. Expedient solid-phase synthesis of both symmetric and asymmetric diol libraries targeting aspartic proteases.
    Shi H, Liu K, Leong WW, Yao SQ.
    Bioorg Med Chem Lett; 2009 Jul 15; 19(14):3945-8. PubMed ID: 19328682
    [Abstract] [Full Text] [Related]

  • 10. Using peptidic inhibitors to systematically probe the S1' site of caspase-3 and caspase-7.
    Goode DR, Sharma AK, Hergenrother PJ.
    Org Lett; 2005 Aug 04; 7(16):3529-32. PubMed ID: 16048334
    [Abstract] [Full Text] [Related]

  • 11. Self-selection in olefin cross-metathesis: the effect of remote functionality.
    McNaughton BR, Bucholtz KM, Camaaño-Moure A, Miller BL.
    Org Lett; 2005 Feb 17; 7(4):733-6. PubMed ID: 15704937
    [Abstract] [Full Text] [Related]

  • 12. Convenient access to glutamic acid side chain homologues compatible with solid phase peptide synthesis.
    Ryan SJ, Zhang Y, Kennan AJ.
    Org Lett; 2005 Oct 13; 7(21):4765-7. PubMed ID: 16209530
    [Abstract] [Full Text] [Related]

  • 13. Extensively stereodiversified scaffolds for use in diversity-oriented library synthesis.
    Gierasch TM, Shi Z, Verdine GL.
    Org Lett; 2003 Mar 06; 5(5):621-4. PubMed ID: 12605474
    [Abstract] [Full Text] [Related]

  • 14. Facile synthesis of @-tide beta-strand peptidomimetics: improved assembly in solution and on solid phase.
    Phillips ST, Piersanti G, Rüth M, Gubernator N, van Lengerich B, Bartlett PA.
    Org Lett; 2004 Nov 25; 6(24):4483-5. PubMed ID: 15548056
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and activity of pseudotripeptide inhibitors of HIV-1 protease containing D(-)-O-(benzyl)tartaric acid.
    Marastoni M, Fantin G, Bortolotti F, Tomatis R.
    Arzneimittelforschung; 1996 Nov 25; 46(11):1099-101. PubMed ID: 8955873
    [Abstract] [Full Text] [Related]

  • 16. Use of olefin cross-metathesis to release azide-containing sugars from solid support.
    Kanemitsu T, Seeberger PH.
    Org Lett; 2003 Nov 27; 5(24):4541-4. PubMed ID: 14627378
    [Abstract] [Full Text] [Related]

  • 17. Novel cyclourethane-derived HIV protease inhibitors: a ring-closing olefin metathesis based strategy.
    Ghosh AK, Swanson LM, Liu C, Hussain KA, Cho H, Walters DE, Holland L, Buthod J.
    Bioorg Med Chem Lett; 2002 Aug 05; 12(15):1993-6. PubMed ID: 12113826
    [Abstract] [Full Text] [Related]

  • 18. Combinatorial synthesis of a small-molecule library based on the vinyl sulfone scaffold.
    Wang G, Yao SQ.
    Org Lett; 2003 Nov 13; 5(23):4437-40. PubMed ID: 14602019
    [Abstract] [Full Text] [Related]

  • 19. Stereocontrolled synthesis and biological activity of two diastereoisomers of the potent HIV-1 protease inhibitor saquinavir.
    Righi G, Ciambrone S, Bonini C, Campaner P.
    Bioorg Med Chem; 2008 Jan 15; 16(2):902-8. PubMed ID: 17964171
    [Abstract] [Full Text] [Related]

  • 20. Disruption of the HIV-1 protease dimer with interface peptides: structural studies using NMR spectroscopy combined with [2-(13)C]-Trp selective labeling.
    Frutos S, Rodriguez-Mias RA, Madurga S, Collinet B, Reboud-Ravaux M, Ludevid D, Giralt E.
    Biopolymers; 2007 Jan 15; 88(2):164-73. PubMed ID: 17236209
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.